Fundraising Fox

Seaport Therapeutics

NASDAQ: SPTX

Boston, US · Founded 2024 · Delaware corporation · 4 known investors

seaporttx.com ↗

Seaport Therapeutics develops therapeutics and medicines. The company is led by a founder with extensive experience building biotech platforms and advancing novel drug development programs.

BiotechMental Healthin /seaport-therapeutics@SeaportTx

Founders & leadership

DZDaphne Zohar
Daphne ZoharFounder, CEO and Board Member
MCMichael Chen
Michael ChenExecutive Officer
LGLana Gladstein
Lana GladsteinExecutive Officer
ALAntony Loebel
Antony LoebelExecutive Officer
EGEric Green
Eric GreenExecutive Officer
JI
James I. HealyDirector
RN
Robert NelsenDirector
BC
Bharatt ChowriraDirector
EE
Eric ElenkoDirector
DW
David WheadonDirector
SPSteven Paul
Steven PaulDirector
DT
Denice TorresDirector

Investors · 4

ARCH Venture PartnersChicago · $50K – $250M
Foresite CapitalLarkspur
HAWKTAILSan Francisco
Sofinnova VenturesMenlo Park · $100K – $15M

Reported raises · per SEC filings

Form D private placements
▶$225.9MraisedOct 2024 · 33 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James I. HealyDirector
  • Michael ChenExecutive Officer
  • Lana GladsteinExecutive Officer
  • Daphne ZoharExecutive Officer, Director
  • Antony LoebelExecutive Officer
  • David WheadonDirector
  • Eric GreenExecutive Officer
  • Robert NelsenDirector
  • Steven PaulDirector
  • Bharatt ChowriraDirector
  • Denice TorresDirector
  • Eric ElenkoDirector
  • Jason PittsDirector
Offering amount
$226M
Amount sold
$225.9M
First sale
Oct 2024
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news